PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical Trial Manager, both from KLIFO, to continue the development of the company's drug candidate PN6047 for the treatment of neuropathic pain.
Inge Tarnow joins the team as the new Senior Project Manager and will lead and coordinate the work with PN6047.
PharmNovo also welcomes Thomas Eskildsen, Senior Clinical Trial Manager. He will oversee the phase I study while being an asset to the team in the planning and managing future phase IIa studies.
Read the full Press release